Carboxypeptidase-mediated enhancement of nitric oxide production in rat lungs and microvascular endothelial cells.
D000818:Animals; D001120:Arginine / Q000378:metabolism / Q000494:pharmacology; D043424:Carboxypeptidase B / Q000378:metabolism*; D002478:Cells, Cultured; D004151:Dipeptides / Q000378:metabolism; D004730:Endothelium, Vascular / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D006868:Hydrolysis; D066298:In Vitro Techniques; D007371:Interferon-gamma / Q000494:pharmacology; D008070:Lipopolysaccharides / Q000494:pharmacology; D008168:Lung / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D008833:Microcirculation; D009569:Nitric Oxide / Q000096:biosynthesis*; D019001:Nitric Oxide Synthase / Q000378:metabolism; D052247:Nitric Oxide Synthase Type II; D052250:Nitric Oxide Synthase Type III; D010477:Perfusion; D011652:Pulmonary Circulation; D051381:Rats; D017207:Rats, Sprague-Dawley
D004151:Dipeptides; D008070:Lipopolysaccharides; D009569:Nitric Oxide; C028060:furylacryloylalanylarginine; D007371:Interferon-gamma; D001120:Arginine; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II; D052250:Nitric Oxide Synthase Type III; C496318:Nos2 protein, rat; C496316:Nos3 protein, rat; D043424:Carboxypeptidase B